A Preliminary Study to Explore Clinical Endpoints in Patients (Male) With Diarrhea-predominant Irritable Bowel Syndrome
A Preliminary Study to Explore Clinical Endpoints in Patients (Male) With Diarrhea-predominant Irritable Bowel Syndrome
The purpose of this study is to explore and examine endpoints that allow evaluation of the
 "clinically significant improvements, focusing on the patient's chief complaint and the
 severity of major IBS symptoms" by this drug in patients with diarrhea-predominant irritable
 bowel syndrome (IBS).
Inclusion Criteria:

 -  Patients meeting the Rome III Diagnostic Criteria

 -  Loose (mushy) or watery stools within the last 3 months

 Exclusion Criteria:

 -  Patients having hyperthyroidism or hypothyroidism